Blue Whale Capital’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Blue Whale Capital's RGEN Position: Q1 2026 in Review
Blue Whale Capital increased its Repligen (RGEN) stake by 31% in Q1 2026, buying an estimated $13.4M and bringing the position to 404,200 shares worth $47.6M. The position accounts for 2.26% of the portfolio, ranked #15.
Blue Whale Capital first reported a position in RGEN in Q2 2025 and has held it in 4 quarters since. The position peaked at $50.5M in Q4 2025. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Blue Whale Capital held 404,200 shares of Repligen worth $47.6M as of Q1 2026.
- Blue Whale Capital bought 95,733 Repligen shares in Q1 2026, an estimated $13.4M.
- Repligen made up 2.26% of Blue Whale Capital's portfolio in Q1 2026, its #15 holding.
- Blue Whale Capital first reported a position in Repligen in Q2 2025 and has held it in 4 quarters since.
- Blue Whale Capital's Repligen position peaked at $50.5M in Q4 2025.
- 442 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Blue Whale Capital's 13F filing for Q1 2026, filed 14 May 2026.